Jacobs Levy Equity Management’s Spectrum Pharmaceuticals SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-594,108
Closed -$255K – 1066
2022
Q3
$255K Buy
+594,108
New +$584K ﹤0.01% 911
2021
Q2
– Sell
-258,662
Closed -$843K – 1144
2021
Q1
$843K Sell
258,662
-527,593
-67% -$1.89M 0.01% 779
2020
Q4
$2.68M Sell
786,255
-313,440
-29% -$1.29M 0.02% 514
2020
Q3
$4.49M Buy
1,099,695
+241,448
+28% +$918K 0.05% 368
2020
Q2
$2.9M Buy
858,247
+602,162
+235% +$1.75M 0.03% 453
2020
Q1
$597K Sell
256,085
-45,789
-15% -$125K 0.01% 723
2019
Q4
$1.1M Buy
+301,874
New +$2.44M 0.01% 675
2017
Q3
– Sell
-117,647
Closed -$876K – 1031
2017
Q2
$876K Sell
117,647
-95,600
-45% -$625K 0.02% 591
2017
Q1
$1.39M Buy
213,247
+168,947
+381% +$945K 0.03% 488
2016
Q4
$196K Buy
+44,300
New +$186K ﹤0.01% 837
2016
Q3
– Sell
-237,901
Closed -$1.56M – 1162
2016
Q2
$1.56M Buy
237,901
+186,361
+362% +$1.32M 0.03% 480
2016
Q1
$328K Buy
51,540
+35,740
+226% +$183K 0.01% 842
2015
Q4
$95K Buy
15,800
+4,200
+36% +$24K ﹤0.01% 744
2015
Q3
$69K Buy
+11,600
New +$80.5K ﹤0.01% 780
2013
Q3
– Sell
-22,600
Closed -$169K – 1041
2013
Q2
$169K Buy
+22,600
New +$173K ﹤0.01% 913

Other funds holding SPPI

Jacobs Levy Equity Management's SPPI Position: Q4 2022 in Review

Jacobs Levy Equity Management sold out of Spectrum Pharmaceuticals (SPPI) in Q4 2022, closing a stake of 594,108 shares — an estimated $255K sold.

Jacobs Levy Equity Management first reported a position in SPPI in Q2 2013 and held it in 15 quarters. The position peaked at $4.49M in Q3 2020. 69 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.

  • Jacobs Levy Equity Management reported no remaining Spectrum Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 594,108 Spectrum Pharmaceuticals shares in Q4 2022, an estimated $255K.
  • Jacobs Levy Equity Management first reported a position in Spectrum Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Jacobs Levy Equity Management's Spectrum Pharmaceuticals position peaked at $4.49M in Q3 2020.
  • 69 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals as of Q4 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.